Quote:

---

One has to be both highly naive and arrogant to just accept everything what NP has done wrong throughout the last weeks.

---

I'll speak for myself, but pretty sure some others feel the same. I am neither naive or arrogant, nor blindly accepting of NP continually overly-optimistic timelines.....but in the same breath, has anything changed with leronlimab? Actually it continues to advance towards the finish line for combo HIV and add other multi-billion potential indications to the fold. The minute I no longer believe this isn't a treatment that will have a substantial impact on many serious diseases and people's lives or remains severely undervalued based on my conservative estimates of these diseases, then I will sell.

What is truly naive and arrogant is for people who know nothing about the science continue to rant endlessly about the CEO, think this stock is going to crash and burn and yet claim to own stock. Why would anyone invest in something they don't believe in or think is worthless? I do understand those long-term shareholders (like Saltz, Lawman, etc.) who are frustrated with the current share price and voicing criticism of NP. Will these concerns still be voiced if a deal closes, BLA is completed, mTNBC results are positive and the share price is higher.....unlikely IMO. The next month or two will be interesting to see if the chants grow louder or are silenced.